echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Female tumor prevention and treatment answer questions.

    Female tumor prevention and treatment answer questions.

    • Last Update: 2020-08-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Ovarian cancer as the leading mortality of gynecological tumors, early diagnosis is still a worldwide problem. Because the symptoms of early ovarian cancer are not obvious, about 70% of ovarian cancer patients are diagnosed with advanced stage, and 70% of patients relapse within 3 years.
    1
    in addition to ovarian cancer, breast cancer, cervical cancer in recent years also frequently in women. For the above female tumor, how to carry out early prevention and early treatment? What strategies has the state adopted for the prevention of female tumors?
    May 8is, World Ovarian Cancer Day, "People's Famous Medical" launched the World Ovarian Cancer Day special planning live broadcast, invited the expert in the field of gynaecological oncology, Fudan University affiliated obstetrics and gynecology hospital party secretary Hua Keqin and Nanjing Medical University First Affiliated Hospital (Jiangsu Provincial People's Hospital) Gynaecology Director Professor Cheng Wenjun for you to explain the relevant doubts about female tumors. Netizen friends related questions can also be raised in the live broadcast, experts will choose the machine to answer.
    Warkqin in reproductive endocrinology, gynaecological oncology and gynaecological minimally invasive medicine has a more in-depth research, especially for gynaecological all kinds of good, malignant tumor minimally invasive surgical treatment, menstrual disorders of all ages, obesity, infertility, endometriosis, uterine prolapse, reproductive malformation and other gynaecological complications have a wealth of clinical experience. Cheng Wenjun is particularly good at the diagnosis and treatment of gynecological malignancies, especially ovarian malignancies surgery, chemotherapy and bio-targeted therapy.
    ",""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" The column is directed to invite the national professional discipline leaders, the leadership of the Hospital of Sanjia and the director of the department, well-known clinical experts and netizens online exchanges.
    live broadcast by the People's Daily Health Client, People's Daily Health Times linked people's video, central video, Tencent News, NetEase News, today's headlines, Baidu Health, Sohu Video, Tencent Video, One Live, Aichi Art, Quick Hand, Beijing Time, JD.com Health, the National Pension Network. One live broadcast, multi-platform inter-link.
    People's Daily health client set health news, disease diagnosis and treatment, academic training trinity, please scan the two-dimensional code, or to the major application stakes to download the search "People's Daily health client" download.
    References:
    1, Xiang Wei, Sun Jifu, Li Yanchun, etc. . . . Advances in the study of serum tumor markers for early screening of ovarian cancer.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.